title: Dynamics of DNA damage induced pathways to cancer.
abstract: Chemotherapy is commonly used in cancer treatments, however only 25% of cancers are responsive and a significant proportion develops resistance. The p53 tumour suppressor is crucial for cancer development and therapy, but has been less amenable to therapeutic applications due to the complexity of its action, reflected in 66,000 papers describing its function. Here we provide a systematic approach to integrate this information by constructing a large-scale logical model of the p53 interactome using extensive database and literature integration. The model contains 206 nodes representing genes or proteins, DNA damage input, apoptosis and cellular senescence outputs, connected by 738 logical interactions. Predictions from in silico knock-outs and steady state model analysis were validated using literature searches and in vitro based experiments. We identify an upregulation of Chk1, ATM and ATR pathways in p53 negative cells and 61 other predictions obtained by knockout tests mimicking mutations. The comparison of model simulations with microarray data demonstrated a significant rate of successful predictions ranging between 52% and 71% depending on the cancer type. Growth factors and receptors FGF2, IGF1R, PDGFRB and TGFA were identified as factors contributing selectively to the control of U2OS osteosarcoma and HCT116 colon cancer cell growth. In summary, we provide the proof of principle that this versatile and predictive model has vast potential for use in cancer treatment by identifying pathways in individual patients that contribute to tumour growth, defining a sub population of "high" responders and identification of shifts in pathways leading to chemotherapy resistance.
authors.affiliation: Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom ; School of Environment and Life Sciences, University of Salford, Salford, United Kingdom.
authors.forename: Kun
authors.initials: K
authors.lastname: Tian
authors.forename: Ramkumar
authors.initials: R
authors.lastname: Rajendran
authors.forename: Manjula
authors.initials: M
authors.lastname: Doddananjaiah
authors.forename: Marija
authors.initials: M
authors.lastname: Krstic-Demonacos
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Schwartz
mesh_terms: D004249:DNA Damage / Q000235:genetics* / Q000502:physiology; D004268:DNA-Binding Proteins / Q000235:genetics; D045325:HCT116 Cells; D006801:Humans; D009369:Neoplasms / Q000209:etiology* / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D025521:Tumor Suppressor Proteins / Q000235:genetics
chemical_list: D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins
references.citation: Oncogene. 2001 Jan 18;20(3):395-8
references.pmid: 11313969
references.citation: Carcinogenesis. 2005 Aug;26(8):1317-22
references.pmid: 15888490
references.citation: Mol Cancer Res. 2003 Dec;1(14):1001-8
references.pmid: 14707283
references.citation: Mol Cancer Ther. 2008 Jun;7(6):1533-42
references.pmid: 18566224
references.citation: Bioinformatics. 2012 Mar 15;28(6):858-66
references.pmid: 22267503
references.citation: Br J Cancer. 2003 Oct 20;89(8):1590-7
references.pmid: 14562036
references.citation: Oncogene. 2005 Dec 15;24(56):8304-13
references.pmid: 16103874
references.citation: BMC Syst Biol. 2012 Sep 15;6:125
references.pmid: 22979979
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):889-900
references.pmid: 15279774
references.citation: Cold Spring Harb Perspect Biol. 2010 Sep;2(9):a001222
references.pmid: 20463003
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6322-7
references.pmid: 20308539
references.citation: Oncogene. 2013 Jun 20;32(25):3039-48
references.pmid: 22869147
references.citation: Mol Cell Biol. 2008 Nov;28(21):6557-67
references.pmid: 18779317
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11250-5
references.pmid: 11016968
references.citation: PLoS One. 2009;4(4):e5131
references.pmid: 19365581
references.citation: J Biol Chem. 2004 Feb 6;279(6):5035-41
references.pmid: 14627709
references.citation: Cancer Lett. 2013 May 28;332(2):237-48
references.pmid: 22261329
references.citation: Mol Cell Biol. 2001 Feb;21(4):1066-76
references.pmid: 11158294
references.citation: J Biol Chem. 1999 Dec 31;274(53):37538-43
references.pmid: 10608806
references.citation: Cancer Sci. 2010 Jul;101(7):1610-7
references.pmid: 20367642
references.citation: PLoS One. 2007 Jun 20;2(6):e547
references.pmid: 17579719
references.citation: Nat Rev Cancer. 2012 Sep;12(9):613-26
references.pmid: 22898542
references.citation: J Biol Chem. 2011 Mar 4;286(9):7339-47
references.pmid: 21156795
references.citation: Nat Cell Biol. 2004 Oct;6(10):968-76
references.pmid: 15448695
references.citation: Sci Signal. 2012 Nov 20;5(251):ra83
references.pmid: 23169817
references.citation: Cell Signal. 2009 Dec;21(12):1794-805
references.pmid: 19666109
references.citation: Cell Cycle. 2009 Jan 1;8(1):105-14
references.pmid: 19106607
references.citation: J Comput Biol. 2009 Jan;16(1):119-32
references.pmid: 19119996
references.citation: Theor Biol Med Model. 2008 Sep 10;5:21
references.pmid: 18783599
references.citation: Oncogene. 2007 Mar 1;26(10):1449-58
references.pmid: 16936775
references.citation: BMC Bioinformatics. 2011 Oct 18;12 Suppl 10:S10
references.pmid: 22165980
references.citation: J Theor Biol. 2009 Aug 21;259(4):760-9
references.pmid: 19422837
references.citation: Nat Clin Pract Oncol. 2008 Sep;5(9):512-20
references.pmid: 18594499
references.citation: Nucleic Acids Res. 2007;35(22):7475-84
references.pmid: 17942417
references.citation: Cell Cycle. 2012 Jun 15;11(12):2367-79
references.pmid: 22672905
references.citation: PLoS Comput Biol. 2009 Dec;5(12):e1000595
references.pmid: 20011108
references.citation: Bioinformatics. 2002 Jan;18(1):207-8
references.pmid: 11836235
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16308-13
references.pmid: 18852469
references.citation: EMBO Rep. 2012 Jun 29;13(7):638-44
references.pmid: 22653443
references.citation: Int J Oncol. 2005 Feb;26(2):493-8
references.pmid: 15645135
references.citation: J Biol Chem. 2010 Feb 12;285(7):4909-19
references.pmid: 19965871
references.citation: Mol Cancer. 2009 Apr 16;8:24
references.pmid: 19371427
references.citation: J Cell Biochem. 2008 May 15;104(2):525-35
references.pmid: 18181212
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D561-8
references.pmid: 21045058
references.citation: Cell Cycle. 2010 Mar 1;9(5):947-52
references.pmid: 20160496
references.citation: BMC Bioinformatics. 2006 Feb 07;7:56
references.pmid: 16464248
references.citation: J Neurochem. 2008 Mar;104(6):1599-612
references.pmid: 17996028
references.citation: Int J Cancer. 2006 Dec 15;119(12):2784-94
references.pmid: 17019715
references.citation: Proc Natl Acad Sci U S A. 2011 May 31;108(22):8990-5
references.pmid: 21576488
references.citation: Genes Dev. 2000 Feb 1;14(3):278-88
references.pmid: 10673500
references.citation: J Pathol. 1999 Jan;187(1):112-26
references.pmid: 10341712
references.citation: Wiley Interdiscip Rev Syst Biol Med. 2010 Jul-Aug;2(4):438-459
references.pmid: 20836040
references.citation: J Biol Chem. 2002 Jan 18;277(3):1864-71
references.pmid: 11707453
references.citation: BMC Syst Biol. 2009 Jan 14;3:7
references.pmid: 19144179
references.citation: Nat Rev Cancer. 2005 Mar;5(3):231-7
references.pmid: 15738985
references.citation: Exp Cell Res. 2004 Aug 15;298(2):329-38
references.pmid: 15265683
references.citation: Science. 2004 Feb 13;303(5660):1010-4
references.pmid: 14963330
references.citation: BMC Syst Biol. 2007 Jan 08;1:2
references.pmid: 17408509
references.citation: Genome Biol. 2007;8(6):R123
references.pmid: 17594483
references.citation: Mol Biol Cell. 2008 Jan;19(1):65-77
references.pmid: 17942597
references.citation: Oncogene. 1999 Sep 23;18(39):5381-92
references.pmid: 10498892
references.citation: Nucleic Acids Res. 2009 Jan;37(Database issue):D412-6
references.pmid: 18940858